GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Median PS Value

Firebrick Pharma (ASX:FRE) Median PS Value : A$0.00 (As of May. 21, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Firebrick Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01. Firebrick Pharma's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is A$0.00.

As of today (2024-05-21), Firebrick Pharma's share price is A$0.063. Firebrick Pharma's Median PS Value is A$0.00. Therefore, Firebrick Pharma's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Firebrick Pharma's Median PS Value or its related term are showing as below:

ASX:FRE's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.85
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Firebrick Pharma Median PS Value Historical Data

The historical data trend for Firebrick Pharma's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Median PS Value Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23
Median PS Value
- - -

Firebrick Pharma Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Median PS Value - - - -

Competitive Comparison of Firebrick Pharma's Median PS Value

For the Drug Manufacturers - General subindustry, Firebrick Pharma's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Firebrick Pharma's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's Price-to-Median-PS-Value falls into.



Firebrick Pharma Median PS Value Calculation

Firebrick Pharma's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.01*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Firebrick Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Firebrick Pharma  (ASX:FRE) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Firebrick Pharma's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.063/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Firebrick Pharma Median PS Value Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Firebrick Pharma (ASX:FRE) Business Description

Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma (ASX:FRE) Headlines

No Headlines